Xinyu Wu Selected Research

Breast Neoplasms (Breast Cancer)

9/2023	Effectiveness and Safety of Palbociclib Plus Endocrine Therapy in Patients with Advanced Breast Cancer: A Multi-Center Study in China.
1/2023	A Retrospective Analysis of Denosumab for the Treatment of Bone Metastases in Chinese Patients With Breast Cancer.
12/2022	WW domain binding protein 2 (WBP2) as an oncogene in breast cancer: mechanisms and therapeutic prospects-a narrative review.
1/2022	Treatment with pyrotinib-based therapy in lapatinib-resistant HER2-positive metastatic breast cancer: a multicenter real-world study.
1/2013	Long chain fatty Acyl-CoA synthetase 4 is a biomarker for and mediator of hormone resistance in human breast cancer.
7/2011	Distinct function of androgen receptor coactivator ARA70α and ARA70β in mammary gland development, and in breast cancer.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Xinyu Wu Research Topics

Disease

31	Neoplasms (Cancer) 12/2023 - 07/2011
10	Inflammation (Inflammations) 10/2023 - 01/2021
8	Osteosarcoma (Osteogenic Sarcoma) 01/2016 - 10/2012
7	Prostatic Neoplasms (Prostate Cancer) 01/2022 - 01/2013
7	Ankylosing Spondylitis 01/2021 - 01/2015
7	Rheumatoid Arthritis 01/2020 - 01/2012
6	Breast Neoplasms (Breast Cancer) 09/2023 - 07/2011
4	Periodontitis 04/2024 - 01/2022
4	Pain (Aches) 01/2024 - 01/2020
4	Hypoxia (Hypoxemia) 01/2024 - 06/2016
4	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 11/2022 - 01/2022
3	Neoplasm Metastasis (Metastasis) 09/2023 - 08/2013
3	Infections 01/2022 - 01/2019
3	Systemic Lupus Erythematosus (Libman-Sacks Disease) 07/2020 - 11/2015
3	Carcinoma (Carcinomatosis) 01/2020 - 01/2011
3	Carcinogenesis 01/2016 - 01/2011
2	Necrosis 01/2024 - 12/2023
2	Myocardial Infarction 04/2023 - 05/2017
2	Pneumonia (Pneumonitis) 01/2023 - 12/2020
2	Asthma (Bronchial Asthma) 01/2023 - 01/2023
2	Hematologic Neoplasms (Hematological Malignancy) 12/2022 - 02/2020
2	Parkinson Disease (Parkinson's Disease) 10/2022 - 07/2020
2	Cardiomyopathies (Cardiomyopathy) 01/2022 - 01/2022
2	Sepsis (Septicemia) 01/2022 - 02/2020
2	Postoperative Pain 06/2021 - 11/2011
2	Gout 02/2021 - 01/2020
2	Experimental Arthritis 01/2020 - 12/2019
2	Disease Progression 01/2018 - 08/2013
2	Ovarian Neoplasms (Ovarian Cancer) 01/2016 - 01/2011
1	Intervertebral Disc Degeneration 05/2024
1	Hypertension (High Blood Pressure) 05/2024
1	Dysbiosis 04/2024
1	Cholangiocarcinoma 03/2024
1	Mitochondrial Diseases (Mitochondrial Disease) 02/2024

Drug/Important Bio-Agent (IBA)

14	Proteins (Proteins, Gene)FDA Link 11/2023 - 01/2012
9	Biomarkers (Surrogate Marker)IBA 09/2023 - 01/2013
7	Ether (Diethyl Ether)IBA 01/2016 - 10/2012
6	Hormones (Hormone)IBA 09/2023 - 01/2011
6	LigandsIBA 01/2022 - 02/2013
6	Androgen Receptors (Androgen Receptor)IBA 06/2016 - 01/2011
5	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2024 - 10/2012
5	MicroRNAs (MicroRNA)IBA 01/2022 - 01/2013
5	Small Interfering RNA (siRNA)IBA 11/2015 - 10/2012
4	Caspase 3 (Caspase-3)IBA 01/2024 - 11/2015
4	Transcription Factors (Transcription Factor)IBA 12/2023 - 01/2013
4	Immunoglobulins (Immunoglobulin)IBA 02/2021 - 11/2015
4	AndrogensIBA 06/2016 - 01/2011
4	Sincalide FDA Link 01/2016 - 01/2013
4	Potassium Channels (Potassium Channel)IBA 01/2016 - 03/2013
3	InterleukinsIBA 01/2024 - 04/2014
3	Fatty Acids (Saturated Fatty Acids)IBA 09/2023 - 01/2014
3	p38 Mitogen-Activated Protein KinasesIBA 06/2023 - 03/2013
3	Estrogen ReceptorsIBA 12/2022 - 07/2011
3	Messenger RNA (mRNA)IBA 01/2022 - 01/2013
3	Co-Repressor ProteinsIBA 06/2016 - 02/2014
3	SteroidsIBA 02/2014 - 01/2013
2	Sirolimus (Rapamycin)FDA Link 02/2024 - 01/2024
2	Caspase 9IBA 01/2024 - 01/2023
2	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2024 - 02/2013
2	Indicators and Reagents (Reagents)IBA 01/2024 - 12/2022
2	Reactive Oxygen Species (Oxygen Radicals)IBA 12/2023 - 01/2022
2	LipidsIBA 12/2023 - 01/2014
2	DNA (Deoxyribonucleic Acid)IBA 11/2023 - 11/2020
2	Dental Implants (Dental Implant)IBA 10/2023 - 01/2022
2	IntegrinsIBA 09/2023 - 09/2022
2	Coenzyme A (CoA)IBA 08/2023 - 01/2014
2	avermectinIBA 06/2023 - 10/2022
2	difenoconazoleIBA 04/2023 - 01/2023
2	CytokinesIBA 01/2023 - 04/2014
2	Oxygen (Dioxygen)IBA 01/2023 - 01/2022
2	AntigensIBA 12/2022 - 01/2022
2	ErbB Receptors (EGF Receptor)IBA 12/2022 - 11/2019
2	rac1 GTP-Binding ProteinIBA 10/2022 - 07/2020
2	Competitive Endogenous RNAIBA 01/2022 - 01/2022
2	Immune Checkpoint InhibitorsIBA 01/2022 - 08/2017
2	HydrogelsIBA 01/2022 - 01/2021
2	Lapatinib (GW572016)FDA Link 01/2022 - 01/2013
2	human ERBB2 proteinIBA 01/2022 - 01/2013
2	EnzymesIBA 01/2022 - 01/2014
2	Therapeutic UsesIBA 06/2021 - 12/2019
2	Uric Acid (Urate)IBA 02/2021 - 01/2020
2	Adalimumab (Humira)FDA Link 01/2021 - 01/2020
2	C-Reactive ProteinIBA 01/2020 - 01/2020
2	Cytoplasmic and Nuclear Receptors (Nuclear Receptors)IBA 06/2016 - 02/2014
1	Becaplermin (PDGF-BB)FDA Link 05/2024
1	Antihypertensive Agents (Antihypertensives)IBA 05/2024
1	Neurokinin-1 Receptor AntagonistsIBA 03/2024
1	Aprepitant (Emend)FDA Link 03/2024
1	Doxorubicin (Adriamycin)FDA LinkGeneric 02/2024
1	Free Radical ScavengersIBA 02/2024
1	ferrostatin-1IBA 02/2024
1	Dacarbazine (DIC)FDA LinkGeneric 02/2024
1	MitoTEMPOIBA 02/2024
1	Superoxides (Superoxide)IBA 02/2024

Therapy/Procedure

19	Therapeutics 05/2024 - 02/2013
8	Drug Therapy (Chemotherapy) 05/2024 - 04/2018
6	Immunotherapy 12/2022 - 06/2018
4	Chinese Traditional Medicine (Traditional Chinese Medicine) 05/2024 - 06/2021
2	Moxibustion 05/2024 - 06/2021
2	Oral Hygiene (Dental Hygiene) 04/2024 - 12/2020